Log inSign up

ALX Oncology

0 followers

‌

ALX Oncology is a publicly traded, clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune system.

Industries

Biotechnology

Headquarters

Burlingame, United States

Employees

11-50

Links

Org chart

Jaume Pons
President & Chief Scientific Officer

Jaume Pons

Collapse
Sophia Randolph
Chief Medical Officer
Athanasios Tsiatis
SVP, Clinical Development
Yeong-Liang Lin
SVP, Drug Safety & Pharmacovigilance
Hank Stern
VP, Chemistry, Manufacturing & Controls
Susan Vermeir
VP, Regulatory Affairs & Quality
Hadi Falahatpisheh
VP, Preclinical Development
Marija Vrljic
VP, Antibody Technologies
Sue Naim
VP, Clinical Operations
Jeanne Jew
Chief Business Officer

Teams

+8

Clinical Development and Operations

11 members

+5

Leadership Team

8 members

+3

Regulatory Affairs and Compliance

6 members

Offices

Similar companies

Tango Therapeutics

2 followers

Septerna

2 followers

Cellares

2 followers

Thermo Fisher Scientific

174 followers

Gilead Sciences

135 followers

Verily Life Sciences

38 followers

BioMarin Pharmaceutical

36 followers

Guardant Health

13 followers

Sarepta Therapeutics

9 followers

PerkinElmer

9 followers

United Therapeutics

8 followers

Explore companies